Turinabol Chlorodehydromethyltestosterone 10 mg

• Brand: Swiss Remedies
• Category: Oral AAS Research Compound
• Content: 100 tablets | 10 mg per tablet (1,000 mg total)
• Manufactured in: Switzerland

Product Overview

Turinabol (CDMT) 10 mg is a synthetic anabolic-androgenic steroid designed for oral administration.

Chemically classified as 4-chlorodehydromethyltestosterone, it is derived from older testosterone-based structures

but modified through chlorination and 17--alkylation to improve stability and oral bioavailability.

Originally developed in the 1960s by Jenapharm (East Germany), Turinabol has become a key research compound in

androgen receptor (AR) pathway studies, anabolic signaling experiments, steroid metabolism profiling, and detection-method development.

Key Research Highlights

AR-mediated anabolic activity:

Turinabol activates the androgen receptor in target tissues, stimulating protein synthesis, nitrogen retention,

and anabolic gene transcription.

Oral bioavailability via 17--alkylation:

Its chemical modifications allow it to resist first-pass metabolism and remain active after ingestion—ideal for

laboratory studies requiring consistent oral dosing.

Metabolic pathway research:

Liver metabolism produces long-term detectable metabolites, making Turinabol important in forensic, anti-doping, and

metabolic studies.

Comparative AAS investigations:

Often used as a benchmark compound to study differences between testosterone derivatives and chlorinated anabolic steroids.

Suggested Laboratory Applications

• Androgen receptor signaling assays
• Anabolic pathway & protein synthesis studies
• Steroid metabolism and biotransformation profiling
• Toxicology and hepatotoxicity modeling of 17--alkylated steroids
• Development of long-term metabolite detection methods

Technical Specifications

PubChem-Supported Research Insights

• Strong AR-binding affinity produces measurable anabolic transcriptional effects
• Chemical modifications enhance oral bioavailability and metabolic stability
• Long-term metabolites assist detection in anti-doping research
• Useful model for analyzing liver enzyme elevation and hepatotoxic pathways
• Supports detailed metabolic profiling using CYP enzyme pathways

Documented Research Side Effects

• Potential hepatotoxicity due to 17--alkylation
• Hormonal suppression affecting endocrine balance
• Changes in lipid profile ( HDL / LDL)
• Possible cardiovascular strain in long-term models
• Androgenic effects: hair loss, acne, shifts in sebaceous activity

Handling & Compliance

For Research Use Only — not for human or veterinary consumption.

Store in a dry, cool environment; protect from light and moisture.

Turinabol is classified as a controlled/banned substance; ensure full compliance with institutional and

jurisdictional regulations before acquisition or use.

Proper documentation, secure storage, and ethical oversight are required for all research applications.